Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Famularo

Showing results (381-390 of 397) with videos related to

Pageof 40
Sort By:
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|February 7, 2022
The largest western experience on salvage hepatectomy for recurrent hepatocellular carcinoma: propensity score-matched analysis on behalf of He.RC.O.Le.Study GroupMaurizio Iaria, Giorgio Bianchi, Federico Fazio, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|March 16, 2022
Benchmarking postoperative outcomes after open liver surgery for cirrhotic patients with hepatocellular carcinoma in a national cohortSimone Famularo, Nadia Russolillo, Matteo Donadon, et al.
Hepatology (Baltimore, Md.)|January 16, 2023
Model to predict major complications following liver resection for HCC in patients with metabolic syndromeGiammauro Berardi, Francesca Ratti, Carlo Sposito, et al.
Langenbeck'S Archives of Surgery|August 10, 2024
Single large hepatocellular carcinoma > 5 cm with surgical indication: is it mandatory a major hepatectomy? a propensity-score weighted analysisMattia Garancini, Matteo Serenari, Simone Famularo, et al.
JAMA Surgery|December 28, 2022
Machine Learning Predictive Model to Guide Treatment Allocation for Recurrent Hepatocellular Carcinoma After SurgerySimone Famularo, Matteo Donadon, Federica Cipriani, et al.
Annals of Surgery|March 30, 2023
Minimally Invasive Versus Open Liver Resections for Hepatocellular Carcinoma in Patients With Metabolic SyndromeGiammauro Berardi, Tommy Ivanics, Gonzalo Sapisochin, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|February 16, 2025
Minimally invasive versus open liver resection for nonmetastatic hepatocellular carcinoma staged BCLC - B and - C: an Italian multicentric analysisGianluca Cassese, Mariano C Giglio, Alessandro Vitale, et al.
JHEP Reports : Innovation in Hepatology|July 4, 2024
Recurrence and tumor-related death after resection of hepatocellular carcinoma in patients with metabolic syndromeGiammauro Berardi, Alessandro Cucchetti, Carlo Sposito, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|January 12, 2025
Laparoscopic versus open resection for hepatocellular carcinoma according to the procedure's complexity: real-world weighted data from a national registerSimone Famularo, Flavio Milana, Francesco Ardito, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|June 25, 2023
Survival benefit of second line therapies for recurrent hepatocellular carcinoma: repeated hepatectomy, thermoablation and second-line transplant referral in a real life national scenarioSimone Famularo, Umberto Cillo, Andrea Lauterio, et al.
Pageof 40

Showing results (381-390 of 397) with videos related to

Sort By:
Pageof 40
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|February 7, 2022
The largest western experience on salvage hepatectomy for recurrent hepatocellular carcinoma: propensity score-matched analysis on behalf of He.RC.O.Le.Study GroupMaurizio Iaria, Giorgio Bianchi, Federico Fazio, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|March 16, 2022
Benchmarking postoperative outcomes after open liver surgery for cirrhotic patients with hepatocellular carcinoma in a national cohortSimone Famularo, Nadia Russolillo, Matteo Donadon, et al.
Hepatology (Baltimore, Md.)|January 16, 2023
Model to predict major complications following liver resection for HCC in patients with metabolic syndromeGiammauro Berardi, Francesca Ratti, Carlo Sposito, et al.
Langenbeck'S Archives of Surgery|August 10, 2024
Single large hepatocellular carcinoma > 5 cm with surgical indication: is it mandatory a major hepatectomy? a propensity-score weighted analysisMattia Garancini, Matteo Serenari, Simone Famularo, et al.
JAMA Surgery|December 28, 2022
Machine Learning Predictive Model to Guide Treatment Allocation for Recurrent Hepatocellular Carcinoma After SurgerySimone Famularo, Matteo Donadon, Federica Cipriani, et al.
Annals of Surgery|March 30, 2023
Minimally Invasive Versus Open Liver Resections for Hepatocellular Carcinoma in Patients With Metabolic SyndromeGiammauro Berardi, Tommy Ivanics, Gonzalo Sapisochin, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|February 16, 2025
Minimally invasive versus open liver resection for nonmetastatic hepatocellular carcinoma staged BCLC - B and - C: an Italian multicentric analysisGianluca Cassese, Mariano C Giglio, Alessandro Vitale, et al.
JHEP Reports : Innovation in Hepatology|July 4, 2024
Recurrence and tumor-related death after resection of hepatocellular carcinoma in patients with metabolic syndromeGiammauro Berardi, Alessandro Cucchetti, Carlo Sposito, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|January 12, 2025
Laparoscopic versus open resection for hepatocellular carcinoma according to the procedure's complexity: real-world weighted data from a national registerSimone Famularo, Flavio Milana, Francesco Ardito, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|June 25, 2023
Survival benefit of second line therapies for recurrent hepatocellular carcinoma: repeated hepatectomy, thermoablation and second-line transplant referral in a real life national scenarioSimone Famularo, Umberto Cillo, Andrea Lauterio, et al.
Pageof 40